Sera Prognostics Q1 net loss narrows to $8.1M; net revenue nil after adjustments

SERA PROGNOSTICS, INC.

2024-Q1 EPS reported -$0.25

Net revenue nil after periodic review of accounting estimates for older tests; gross revenue $39K vs $100K YoY.
Net loss $8.1M, improved 24% from $10.6M loss in Q1 2023.
Operating expenses $9.1M, down 20% YoY; SG&A $5.4M (-26%), R&D $3.7M (-10%).
Shipped first ambient whole blood collection kits to reduce COGS and expand access.
Submitted PRIME study interim analysis manuscript for peer-reviewed publication.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SERA PROGNOSTICS, INC. reported first quarter ended March 31, 2024 results: revenue nil, net income $8.1 million loss.

Period: first quarter ended March 31, 2024
Revenue: nil
Net income: $8.1 million loss
Result: reported results

Exact text from the filing

First quarter 2024 revenue before adjustments was $39,000 compared to $100,000 for the same period of 2023, but net revenue was nil after our periodic review of accounting estimates for older tests.

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

SERA PROGNOSTICS, INC. filing history →

Source: SEC EDGAR

accession 0001534969-24-000084

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.